|
|
???tair.name??? >
???browser.page.title.author???
|
"muzaffar s"???jsp.browse.items-by-author.description???
Showing items 1-2 of 2 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 中山醫學大學 |
2021 |
Year-3 Observational Follow-up of Belimumab Safety (Mortality and Malignancies) in Patients with SLE Who Completed a Phase 4, 52-Week, Randomized, Double-Blind Placebo-Controlled Safety Study
|
Sheikh, S; Wei, CC; Tegzova, D; Stohl, W; de Toledo, RA; Mucenic, T; Banfi, MA; Maksimowicz-McKinnon, K; Abud-Mendoza, C; Navarra, S; Garcia, M; Garcia-De La Torre, I; Kurrasch, R; Fernandes, S; Harris, J; Muzaffar, S; Fox, NL; Liu, A; Quasny, H; Roth, D |
| 中山醫學大學 |
2021 |
SAFETY OF BELIMUMAB IN PATIENTS WITH ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS: YEAR 2 FOLLOW-UP OF A LARGE PHASE 4, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
|
Sheikh, S; Scheinberg, M; Wei, JCC; Tegzova, D; Stohl, W; Mucenic, T; Punwaney, R; Kurrasch, R; Harris, J; Muzaffar, S; Fernandes, S; Fox, NL; Liu, A; Quasny, H; Roth, D |
Showing items 1-2 of 2 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
